featured research

Clinical and translational research at Vanderbilt will be funded over the next five years, thanks to a $46 million renewal grant from the National Center for Advancing Translational Sciences. (Mary Donaldson/Vanderbilt)
July 12, 2012

Vanderbilt’s CTSA lands $46 million renewal

Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million.

By Bill Snyder
Neurons with serotonin transporters labeled with quantum dots. (Jerry Chang / Vanderbilt)
June 27, 2012

Probing the roots of depression by tracking serotonin regulation at a new level

An interdisciplinary team of scientists have successfully tagged a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of individual molecules for the first time. This capability makes it possible to study the manner in which serotonin regulates mood, appetite and sleep at a new level of detail.
mother and baby
June 22, 2012

Kids’ cells okay after mom’s cancer radiation

Study finds no evidence of increased mitochondrial mutations in the children of women treated with radiation for cancer.

By VUMC News and Communications
Insulin in vials
June 15, 2012

Family members can often sabotage diabetes care: study

Nonsupportive family members contribute to poor adherence to medication regimens and lower glycemic control in adults with diabetes.

By Craig Boerner
report card
June 12, 2012

Mixed results define 2012 Tennessee Men’s Health Report Card

Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card.

By Craig Boerner
June 12, 2012

Making order out of ordinal data

A new statistical tool developed by Vanderbilt biostatisticians will help medical researchers make sense of a commonly encountered – but hard-to-analyze – type of data.

By Leigh MacMillan
June 11, 2012

Vanderbilt identifies genes linked to breast cancer chemo resistance

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
By VUMC News and Communications
June 8, 2012

Study sees eligibility confusion ahead for Affordable Care Act applicants

A Vanderbilt expert on health policy and economics says that many people who get subsidized private health insurance under the Affordable Care Act in 2014 could face confusing changes in eligibility and cost sharing, and some will be required to pay the government back after the first year of participation.
By VUMC News and Communications
May 15, 2012

New clue to ADHD

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
By Bill Snyder
May 14, 2012

Intestinal artillery launches anti-bacterial attack

The epithelial cells that line the intestines have a newly discovered mechanism for protecting us against microbes: they fire anti-bacterial "bullets" into the gut.
By Leigh MacMillan
May 10, 2012

Vision study changes how we see the brain

Vanderbilt researchers have discovered that the pulvinar, a mysterious structure buried in the center of our brains, determines how we see the world — and whether we see at all.
By Bill Snyder
April 26, 2012

New drug mutes more melanomas

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
By VUMC News and Communications
April 19, 2012

MRSA in pregnancy may be less dangerous than previously thought

Vanderbilt pediatric infectious disease researchers studying antibiotic-resistant staph say fears that mothers carrying the germ may set their newborns up for infection are unfounded.
By VUMC News and Communications
1 … 7 8 9 10 11 … 13